Dr. Rizvi on Nivolumab Plus Erlotinib in Patients with EGFR MT NSCLC - 100280

Spotlight
Video

Dr. Rizvi on Nivolumab Plus Erlotinib in Patients with EGFR MT NSCLC

onclivetv has 407 videos Subscribe Here

Loading........
Description: Naiyer A. Rizvi, MD, an associate attending physician, Memorial Sloan Kettering Cancer Center, discusses the safety and response with plus erlotinib in patients with epidermal growth factor receptor mutant (EGFR MT) advanced non-small cell lung cancer (NSCLC).
Shared By : onclivetv
Posted on : 06/11/14
Added : 4 years ago